UPLOAD Filing
Enveric Biosciences, Inc.
Date: April 27, 2026 · CIK: 0000890821 · Accession: 0000000000-26-004265
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295273
Letter
April 27, 2026 Joseph Tucker, Ph.D. Chief Executive Officer Enveric Biosciences, Inc. 245 First Street, Riverview II, 18th Floor Cambridge MA, 02142 Re: Enveric Biosciences, Inc. Registration Statement on Form S-3 Filed April 23, 2026 File No. 333-295273 Dear Joseph Tucker, Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Rasika A. Kulkarni, Esq.
Show Raw Text
April 27, 2026
Joseph Tucker, Ph.D.
Chief Executive Officer
Enveric Biosciences, Inc.
245 First Street, Riverview II, 18th Floor
Cambridge MA, 02142
Re: Enveric Biosciences, Inc.
Registration Statement on Form S-3
Filed April 23, 2026
File No. 333-295273
Dear Joseph Tucker, Ph.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Rasika A. Kulkarni, Esq.